Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Direct links to NCBI, no account and no request form: the whole study as GSE97682_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 155 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA382641 and SRA study SRP103825. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 155 more — browse all 155 samples with per-sample file links →
- GSE254521 Epigenetic priming promotes acquisition of TKI resistance and oncogene amplification in human lung cancer 146 samples
- GSE254366 Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated CRC. 36 samples
- GSE254244 Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes 112 samples
- GSE283621 Single-cell multi-omics analysis identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma 79 samples
- GSE331167 Photoproximity labeling of c-Myc reveals SLK as a cancer-specific co-regulator 47 samples
- GSE287279 Combined SNPs sequencing and allele specific proteomics capture reveal functional causality underpinning the 2p25 prostate cancer susceptibility locus 44 samples
- GSE210848 Lineage specific chromatin modification guides Pax5 mediated gene expression in neuroendocrine like differentiation of prostate cancer 32 samples
- GSE322964 Single cell and spatial sequencing analysis of cancer associated fibroblasts in the brain metastasis tumor microenvironment [Multiome] 22 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.